Back to News
Ori Biotech addressing issues in patients accessing advanced cell and gene therapies.
![View Ori Biotech discusses why paper is the enemy of scale in CGT manufacturing Paper is the enemy of scale in CGT manufacturing](https://oribiotech-com.nimbus-cdn.uk/wp-content/uploads/2022/03/paper-6276204_1280-454x263.png?format=webp&nv=e620130e-1fcb-4adf-875f-03b3d695bdfc)
Ori Biotech discusses why paper is the enemy of scale in CGT manufacturing
www.bioprocessintl.com
![View Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech Ori Biotech CGT](https://oribiotech-com.nimbus-cdn.uk/wp-content/uploads/2022/01/microbiology-163470-454x263.jpg?format=webp&nv=e620130e-1fcb-4adf-875f-03b3d695bdfc)
Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech
https://www.fiercepharma.com
![View Regulatory challenges and success in Series B: an interview with Jason C. Foster Cell and Gene therapy](https://oribiotech-com.nimbus-cdn.uk/wp-content/uploads/2022/02/AdobeStock_346105860-min-scaled-1-454x263.jpeg?format=webp&nv=e620130e-1fcb-4adf-875f-03b3d695bdfc)
Regulatory challenges and success in Series B: an interview with Jason C. Foster
www.regmednet.com